Establishment of higher passage PER.C6 cells for adenovirus manufacture

Biotechnology Progress

Volumn 24, Issue 1, 2008, Pages 158-165

  Berdichevsky, Marina ^a   Gentile, Marie Pierre ^a   Hughes, Benjamin ^a,b   Meis, Peter ^a,c   Peltier, Joseph ^a,d   Blumentals, Ilse ^a,e   Auniņš, John ^a   Altaras, Nedim Emil ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d University of California   (United States)

^e GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CELL CULTURE; CELL PROLIFERATION; GLUCOSE; METABOLISM; VIRUSES;

CELL DENSITIES; CELL PHYSIOLOGY; POPULATION DOUBLING LEVEL; REPLICATION-DEFICIENT ADENOVIRUS;

CELL GROWTH;

ADENOVIRUS; CELL LINE; CELL PROLIFERATION; CONFERENCE PAPER; CULTURE TECHNIQUE; GROWTH, DEVELOPMENT AND AGING; HUMAN; METHODOLOGY; VIRUS CULTURE;

ADENOVIRIDAE; CELL CULTURE TECHNIQUES; CELL LINE; CELL PROLIFERATION; HUMANS; VIRUS CULTIVATION;

ADENOVIRIDAE; BACTERIA (MICROORGANISMS);

EID: 38949098174     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp070258u     Document Type: Conference Paper

References (32)

1. Altaras, N. E.; Aunins, J. G.; Evans, R. K.; Kamen, A.; Konz, J. O.; Wolf, J. J. Production and formulation of adenovirus vectors. Adv. Biochem. Eng./Biotechnol. 2005, 99, 193-260.
2. Kamen, A.; Henry, O. Development and optimization of an adenovirus production process. J. Gene Med. 2004, 6, S184-S192.
3. Shiver, J. W.; Emini, E. A. Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors. Annu. Rev. Med. 2004, 55, 355-372.
4. Graham, F. L.; Smiley, J.; Russell, W. C.; Nairn, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 1977, 36, 59-74.
5. Fallaux, F. J.; Bout, A.; Velde, I. V. D.; Wollenberg, D. J. M.; Hehir, K. M.; Keegan, J.; Auger, C.; Cramer, S. J.; Ormondt, H.; Eb, A. J.; Valerio, D.; Hoeben, R. C. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum. Gene Ther. 1998, 9, 1909-1917.
6. Ferreira, T. B.; Ferreira, A. L.; Carrondo, M. J. T.; Alves, P. M. Effect of refeed strategies and non-ammoniagenic medium on adenovirus production at high cell densities. J. Biotechnol. 2005, 119, 272-280.
7. Ferreira, T. B.; Carrondo, M. J. T.; Alves, P. M. Effect of ammonia production on intracellular pH: Consequent effect on adenovirus vector production. J. Biotechnol. 2007, 129, 433-438.
8. Zhang, C.; Ferreira, T. B.; Cruz, P. E.; Alves, P. M.; Haury, M.; Carrondo, M. J. T. The importance of 293 cell cycle phase on adenovirus vector production. Enzyme Microb. Technol. 2006, 39, 1328-1332.
9. Xie, L.; Pilbrough, W.; Metallo, C.; Zhong, T.; Pikus, L.; Leung, J.; Auniņš, J.; Zhou, W. Serum-free suspension cultivation of PER.C6 cells and recombinant adenovirus production under different pH conditions. Biotechnol. Bioeng. 2002, 80, 569-579.
10. Maranga, L.; Auniņš, J. G.; Zhou, W. Characterization of changes in PER.C6 cellular metabolism during growth and propagation of a replication-deficient adenovirus vector. Biotechnol. Bioeng. 2005, 90, 645-655.
11. Ledwith, B. J.; Lanning, C. L.; Gumprecht, L. A.; Anderson, C. A.; Coleman, J. B.; Gatto, N. T.; Balasubramanian, G.; Farris, G. M.; Kemp, R. K.; Harper, L. B.; Barnum, A. B.; Pacchione, S. J.; Mauer, K. L.; Troilo, P. J.; Brown, E. R.; Wolf, J. J.; Lebron, J. A.; Lewis, J. A.; Nichols, W. W. Tumorigenicity assessments of PER.C6 cells and of Ad5-vectored HIV-1 vaccine produced on this continuous cell line. Dev. Biol. (Basel) 2006, 123, 251-263.
12. Shabram, P. W.; Giroux, D. D.; Gourdreau, A. M.; Gregory, R. J.; Horn, M. T.; Huyghe, B. G.; Liu, X.; Nunnally, M. H.; Sugarman, B. J.; Sutjipto, S. Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles. Hum. Gene Ther. 1997, 8, 453-465.
13. Konz, J. O.; Livingood, R. C.; Bett, A. J.; Goerke, A. R.; Laska, M. E.; Sagar, SL. Serotype specificity of adenovirus purification using anion-exchange chromatography. Hum. Gene Ther. 2005, 16, 1346-1353.
14. Maranga, L.; Goochee, C. F. Metabolism of PER.C6 cells cultivated under fed-batch conditions at low glucose and glutamine levels. Biotechnol. Bioeng. 2006, 94, 139-150.
15. Yallop, C.; Crowley, J.; Cote, J.; Hegmans-Brouwer, K.; Lagerwerf, F.; Gagne, R.; Martin, J. C.; Oosterhuis, N.; Opstelten, D-J.; Bout, A. PER.C6 cells for the manufacture of biopharmaceutical proteins. Mod. Biopharm. 2005, 779-807.
16. Chun, C.; Heineken, K.; Szeto, D.; Ryll, R.; Chamow, S.; Chung, JD. Application of factorial design to accelerate identification of CHO growth factor requirements. Biotechnol. Prog. 2003, 19, 52-57.
17. Rasmussen, B.; Davis, R.; Thomas, J.; Reddy, P. Isolation, characterization and recombinant protein expression in Veggie-CHO: A serum-free CHO host cell line. Cytotechnology. 1998, 28, 31-42.
18. Sinacore, M. S.; Drapeau, D.; Adamson, S. R. Adaptation of mammalian cells to growth in serum-free media. Mol. Biotechnol. 2000, 15, 249-257.
19. Park, M. T.; Lee, M. S.; Kim, S. H.; Jo, E-C.; Lee, G. M. Influence of culture passages on growth kinetics and adenovirus vector producion for gene therapy in monolayer and suspension cultures of HEK 293 cells. Appl. Microbiol. Biotechnol. 2004, 65, 553-558.
20. Koller, M. R.; Manchel, I.; Palsson, M. A.; Maher, R. J.; Palsson, B. Ø. Different measures of human hematopoietic cell culture performance are optimized under vastly different conditions. Biotechnol. Bioeng. 1996, 50, 505-513.
21. Kallos, M. S.; Behie, L. A. Inoculation and growth conditions for high-cell-density expansion of mammalian neural stem cells in suspension bioreactors. Biotechnol. Bioeng. 1999, 63, 473-483.
22. Murhammer, D. W.; Goochee, C. F. 1988. Scaleup of insect cell cultures: Protective effects of Pluronic F-68. Biotechnology 1988, 6, 1411-1418.
23. Grewal, S. S.; Edgar, B. A. Controlling cell division in yeast and animals: does size matter? J Biol. 2003, 2, 5.
24. Stocker, H.; Hafen, E. Genetic control of cell size. Curr. Opin. Genet. Dev. 2000, 10, 529-535.
25. Rouzaire-Dubois, B.; Malo, M.; Milandri, J-B.; Dubois, J-M. Cell size-proliferation relationship in rat glioma cells. Glia 2003, 45, 249-257.
26. Conlon, I.; Raff, M. Size control in animal development. Cell 1999, 96, 235-244.
27. Frame, K. K.; Hu, W-S. Cell volume measurement as an estimation of mammalian cell biomass. Biotechnol. Bioeng. 1990, 36, 191-197.
28. Nadeau, I.; Kamen, A. Production of adenovirus vector for gene therapy. Biotechnol. Adv. 2003, 20, 475-489.
29. Bello, L. J.; Ginsberg, H. S. Inhibition of host protein synthesis in type 5 adenovirus-infected cells. J. Virol. 1967, 1, 843-850.
30. Hodge, L. D.; Scharff, M. D. Effect of adenovirus on host cell DNA synthesis in synchronized cells. Virology 1969, 37, 554-564.
31. Lloyd, D. R.; Holmes, P.; Jackson, L. P.; Emery, A. N.; Al-Rubeai, M. Relationship between cell size, cell cycle and specific recombinant protein productivity. Cytotechnology 2000, 34, 59-70.
32. Gilbert, P-A.; Garnier, A.; Jacob, D.; Kamen, A. On-line measurement of green fluorescent protein (GFP) fluorescence for the monitoring of recombinant adenovirus production. Biotechnol. Lett. 2000, 22, 561-567.